Abstract | Much of contemporary synthetic biology research relies on the use of bacterial chassis for plugging-in and plugging-out genetic circuits and new-to-nature functionalities. However, the microorganisms that are the easiest to manipulate in the laboratory are often suboptimal for downstream industrial applications, which can involve physicochemical stress and harsh operating conditions. In this Review, we advocate the use of environmental Pseudomonas strains as model organisms that are pre-endowed with the metabolic, physiological and stress-endurance traits that are demanded by current and future synthetic biology and biotechnological needs.
The tombstone of Selman Waksman (1888-1973) -the discoverer of streptomycin -bears the biblical quote "The earth will open and bring forth salvation". The benefits that antibiotics produced by soil microorga nisms have brought to mankind have undoubtedly been immense. However, Waksman could not imagine during his lifetime the phenomenal range of microbial activities concealed in the soil microbiota that could be exploited for human interests. Environmental bacteria not only control global biogeochemical cycling, they also have an amazing repertoire of biochemical activities. Since the mid1980s, the development of recombinant DNA tech nology to manipulate environmental bacterial hosts has enabled the production of new bioactive molecules 1,2 and the treatment of xenobiotic chemical wastes 3, 4 , among other applications. Attempts to capitalize on microbial soil diversity have recently expanded to include the min ing of environmental genes in both complete bacterial genomes 5 and metagenomes 6 , by the use of functional traps 7, 8 and/or bioinformatic approaches 9 . Genetic engineering techniques were historically used to accomplish these endeavours, although most strategies lacked an authentic engineering perspective, either technically or conceptually, and mostly depended on trialanderror attempts. By contrast, contemporary synthetic biology addresses the same type of challenges but involves a genuine forward-engineering approach [10] [11] [12] .
One of the key components of this endeavour is the use of specific biological chassis (FIG. 1) , into which users can plugin and plugout genetic circuits and thereby bring about newtonature properties at will. The metaphor of a chassis has become commonplace in synthetic bio logy 13 ; the term evokes the image of an internal frame work that supports a manmade object. A bacterial genome, edited where necessary, provides a material frame on which rationally engineered biological compo nents can be placed. The chassis metaphor suggests that the implanted components (genetic or otherwise) are autonomous with respect to the physiology of the cell in which the chassis is present and suggests that it is possi ble to confer predictable properties to biological entities. Unfortunately, unlike the mechanical or electrical parts that are used in engineering, biological components function in an extremely contextdependent manner, as they interact with metabolites and (bio)chemicals, are subjected to Darwinian evolution, can confer emergent properties when combined and the cells that harbour these components grow and multiply. Overcoming -or at least mitigating -these problems is a fundamental part of the synthetic biology research agenda 14 . Selecting a specific bacterium as a chassis for synthetic biology applications can be viewed as being analogous to the selection of animal species for domestication 15 -few species are suitable for this process. One key aspect of the domestication process involves an innate potential (which can be enhanced by breeding) to pre dictably follow instructions from a master. Similarly, a reliable microbial chassis that is suitable for synthetic biology should ideally be derived from bacterial species that are naturally preendowed with several appealing physiological and metabolic properties and are amenable to stable genetic reprogramming. The synthetic biology
Forward-engineering
The rational design of complex objects with properties that can be quantitatively predicted from the attributes of the components.
Biological chassis
An autonomous genetic and/or biochemical scaffold that functions as an dynamic platform for implanting forward-designed biological devices.
pursuit of biological chassis that can be subjected to deep (and rational) genetic engineering has naturally intersected with the more conventional search for the microbial platform strains and cell factories that are most favourable for consolidated bioprocesses, which are trademarks of modern industrial biotechnology 16, 17 . Over time, researchers have been able to domesticate a few bacteria for different purposes, most notably Escherichia coli and Bacillus subtilis.
An ideal bacterial chassis has a genome that encodes the basic biological functions required for selfmaintenance, growth and stress resistance, but is deleted of other cell structures and signalprocessing components that divert resources. Under natural circumstances, these functions enable microorganisms to interact with their environment, but they may not be required in the syn thetic biology laboratory or in biotechnological settings. Such strains must be robust, stable and easily amenable to genetic manipulations, but must also have low spon taneous variability and physically strong envelopes that can survive operating conditions in bioreactors 18 . Having efficient transcription-translation systems and a predict able metabolic background is also desirable. Moreover, easy downstream processing (that is, recovery and puri fication of products and recycling or disposal of wastes) is undoubtedly important.
Although biotechnology has historically dealt with a large variety of platform strains and cell factories, starting with the production of acetone by Clostridium acetobutylicum 19 in 1916, E. coli has been the micro organism of choice for advanced genetic engineering since the start of the recombinantDNA era. Not sur prisingly, the same bacterium has become the preferred choice for most synthetic biology applications 20 . How ever, is this organism really the only bacterium that can be used in both fundamental synthetic biology and applied biotechnology? Nature has its own way of allowing bacteria to develop novel traits by which individuals and populations can gain a competitive advantage. One archetypal case is that of soil microorganisms that encounter xenobiotic contaminants 21 . In this scenario, bacteria can evolve to have new metabolic pathways to use the new chemical (or chemicals) as a carbon source. The process can be thought of as the encounter of a genetic 'landscape' with a novel chemical landscape 21, 22 . Genotypic and metabolic innovations in such natural settings seem to be elicited by both nutritional and physicochemical environmental stresses [21] [22] [23] [24] [25] . We argue that the synthetic biology com munity should take advantage of this natural innovation. Although E. coli constitutes an optimal experimental model to test and validate foundational technologies, the largescale deployment of syntheticbiologyderived activities requires a choice of available hosts. The pro duction of complex biofuels and other addedvalue molecules, as well as the biodegradation of recalcitrant chemicals, often proceed through the accumulation of intermediates that are toxic for E. coli 26 . In this context, several species of the genus Pseudomonas seem to ful fill many of the conditions that are required of an ideal platform strain or microbial cell factory [16] [17] [18] . In this Review, we present the case that strains from the genus Pseudomonas (and specifically, of Pseudo monas putida) are evolutionarily endowed with many of the prop erties that synthetic biologists are currently attempting to develop artificially in other microbial platforms.
Why Pseudomonas spp.?
The genus Pseudomonas encompasses a large number (>200 and growing 27 ) of Gramnegative, aerobic gamma proteobacterial species 28 . The name derives from 'pseudes' (meaning false) and 'monas' (meaning single unit) and was proposed to broadly designate a genus of non sporulating rodshaped bacteria that have polar fla gella 29 . Although biochemical tests and sequencing of 16S rRNA genes have helped to distinguish members within the group, the pseudomonad classification criteria are still controversial 30 . Relevant features that are shared by many Pseudomonas species include their abil ity to adapt to different physicochemical and nutritional niches (FIG. 2) , their remarkable capacity to endure both endogenous and exogenous stresses and their ability to synthesize many bioactive compounds (including anti biotics 31 ). These traits are encoded by approximately 1,500 genes 32 , which are common to all Pseudomonas species that have been sequenced so far.
The fact that many Pseudomonas species are human and plant pathogens can be attributed to the production of various virulence factors 33 and the ability of these bac teria to evolve quickly 34 , which enables the development of resistance to numerous antibiotics. Many metabolic genes have been identified as key factors that are involved in the virulence of some Pseudomonas species. In particu lar, the distinct arrangement of glycolytic pathways in this class of bacteria 35 Figure 1 | The quest for an optimal synthetic biology chassis. The view of a well-defined genomic framework as a biological chassis for 'plugging-in' and 'plugging-out' genetic circuits and new-to-nature activities is one of the most powerful metaphors of synthetic biology 14 . Such self-replicating chassis should be capable of predictably carrying out a number of background, housekeeping and pre-defined cellular tasks, which must, in turn, support the functional, long-term operation of engineered traits in a biological system (for example, a bacterial cell). Ideally, new functionalities are inserted by means of standardized genetic tools, which are often based on plasmids or transposon vectors. The most desirable characteristics of the ideal synthetic biology chassis for biotechnology 18, 134 are often naturally found in microorganisms other than Escherichia coli or Mycoplasma spp. One key aspect of engineering predictable synthetic biology agents is the control of the chassis-implant retroactivity (the biological equivalent of impedance 135 ), which often leads to unexpected changes in the behaviour of a circuit, and even to its complete collapse. This requires adequate tuning of the instructions from the inserted DNA with the physiology of the recipient cells 37 .
exopolysaccharide that is produced by Pseudomonas aeruginosa and which is known to be a virulence factor in lung infections of patients with cystic fibrosis, has its origins in central metabolic intermediates 36 . The oxida tive stress that P. aeruginosa may experience during the colonization of host tissues is counteracted by the activity of central pathways, owing to the generation of reducing equivalents 37 . In fact, a genomewide metabolic model of P. aeruginosa 38 suggested that the prevalence of the Entner-Doudoroff pathway and pentose phosphate path way for carbohydrate consumption is an important meta bolic asset for infection (FIG. 3) . This tradeoff, which is shared by virtually all pseudomonads and which involves a high NADPH regeneration rate 39 , enables the evolution and expression of biochemical pathways that would be barely tolerated by other bacterial species 37 . The presence of multiple membranebound pumps that are involved in antibiotic extrusion in virulent strains 40, 41 also has a beneficial effect in nonpathogenic strains, as reflected by the presence of solventtolerance efflux pumps 42 . However, the same metabolic vigour that makes some strains virulent makes others suitable to host and evolve new chemical reactions 37 . The Pseudomonas spp. strains that could potentially be used as platform strains and cell factories in various biotechnological settings are those that retain the inherent beneficial traits (for example, catalytic vigour) but that lack undesirable traits (for example, virulence factors). The branch of the Pseudomonadaceae family that is most appealing in this regard is centred around the nonpathogenic P. putida species. Several relevant qualities that are shared by strains of this species are discussed below.
General characteristics of P. putida. P. putida has been a laboratory model for examining the lifestyle and activi ties of environmental bacteria 43, 44 . This microorganism made headlines in the late1970s in the 'Diamond versus Chakrabarty' patent case 45 as a bacterium that is capable of breaking down oil and thus has potential for the biore mediation of petroleum spills. Some P. putida isolates colonize the rhizosphere 46 and establish beneficial rela tionships with plants 47 by feeding on root exudates and releasing siderophores, antibiotics and biosurfactants 48, 49 . Several environmental strains of P. putida can mineral ize aromatic hydrocarbons, chloro and nitroorganic compounds, pesticides, herbicides and even explosive chemicals 50 . Owing to this trait, this bacterium is an excellent host to explore inconspicuous reactions in metagenomic libraries. The use of P. putida as a host facilitated the implementation of gene traps 8, 51 as a screening method to discover biodegradation processes, owing to the responsiveness of P. putida transcriptional factors to various effectors (FIG. 4) . The extant metabolic diversity of P. putida 50 also includes a metabolic profile 
Figure 2 | Ecological habitats of Pseudomonas spp.
Bacteria from the genus Pseudomonas can thrive in a broad variety of niches, which range from natural environments to human-associated ecosystems 46, 49 . Members of this genus can be found on the surface of plants (for example, Pseudomonas fluorescens and Pseudomonas syringae), whereas others are common rhizosphere and soil colonizers (for example, Pseudomonas putida KT2440 and P. fluorescens). Several species have also been isolated from water (for example, P. fluorescens and P. putida GB-1), from insects (for example, Pseudomonas entomophila) and from humans (for example, Pseudomonas aeruginosa). Several Pseudomonas spp. are often located in soils that have a history of pollution by chemical wastes.
that is likely to change when cells grow in close proxim ity to other species 52 . This phenomenon, which is well established in P. aeruginosa 53 , suggests the existence of a cryptic metabolic complement that is expressed under specific circumstances and enables the use of diffusible metabolites as communication signals to be exploited for engineering intercellular communication 54 . P. putida is often able to withstand exposure to high concentrations of organic solvents, which makes it appealing as a biocatalyst for biotransformations in twophase systems 39, 55 (that is, fermentations in which the substrates and the products partition between an aqueous phase and a nonaqueous immiscible phase). In the late1980s, the Horikoshi laboratory 56 showed that an isolate of Pseudomonas spp. (later classified as P. putida) thrived in the presence of toluene at concentrations of up to 50% (v/v). Toluene is an aromatic and highly noxious chemical that kills most microorganisms at concentra tions as low as 0.1% (v/v). Other P. putida strains that are able to endure high concentrations of the same chemical in the medium have also been reported 57, 58 . How does P. putida thrive under such adverse conditions? Much of this tolerance can be attributed to the action of efflux pumps that extrude toluene (and possibly other sol vents) to the external medium 59 . The effect of pumps is complemented by other physiological changes 59 . Expo sure to organic solvents also induces protein unfold ing, which stimulates a general response mediated by extracytoplasmic σfactors that trigger the expression of molecular chaperones and other stressresistance pro teins 60 . Again, these features show the genetic prepro gramming of P. putida to deal with a hydrophobic milieu, which is desirable for some types of biocatalysis. Ideally, solvent tolerance in a given biotransformation is paral leled by resistance to the toxic effects that are caused by the products and/or intermediates. In this respect, it is worth mentioning the high butanol tolerance of some pseudomonads 61 ; not surprisingly, the expression of genes for butanol biosynthesis from C. acetobutylicum in P. putida 62 resulted in alcohol titres of up to 120 mg per L.
One final feature of P. putida that makes it an inter esting choice for the downstream applications of syn thetic biology is its ability to react to an excess of carbon relative to other essential elements (for example, nitro gen or phosphorus) by accumulating intracellular polyester granules as storage material 63, 64 . The biotech nological interest in these compounds stems from their plastic properties, biodegradability and the broad range of qualities that stem from the side chains present in the polymers. In fact, polyhydroxyalkanoates have the potential to replace conventional, oilderived plastics in several packaging and coating applications 65 . Although most polymerproducing microorganisms (including recombinant E. coli 66 ) accumulate shortchain variants -for example, poly(3hydroxybutyrate) -P. putida can incorporate linear and branched C 6-16 monomers of 3hydroxy fatty acids in the chains, thereby producing mediumsidechain polyhydroxyalkanoates 67, 68 . More over, the coupling of biopolymer accumulation and deg radation has a key role in the overall carbon balance of P. putida 69 . Mediumsidechain polymers have improved elastomeric properties compared with shortsidechain counterparts, which enables chemical derivatization of the bioplastic. Tailormade biopolymer production using P. putida thus enables a multilevel optimization approach, which encompasses not only the engineering of the chas sis and the key enzymes (for example, biopolymer syn thases) but also the design of fermentation strategies and the introduction of chemical modifications 70, 71 . P. putida KT244. The most prominent P. putida strain is called KT2440 (KT stands for Kenneth Timmis, who characterized this specimen 72 ). This bacterium is a deriv ative of an environmental isolate known as Pseudomonas arvilla mt2 (REF. 73 ), which was reported to express an enzyme that cleaves the aromatic ring of mtoluate 74 . Glycolysis (from 'glykys', meaning sweet, and 'lysis', meaning splitting) is the metabolic process that converts glucose into pyruvate. The free energy that is released from these bioreactions is used to form high-energy bonds (in ATP) and reducing equivalents (such as NADH), while converting the substrate into biomass-building blocks. The Embden-Meyerhof-Parnas (EMP) pathway is the archetypal hexose-breakdown route; however, the term glycolysis also refers to other pathways, such as the EntnerDoudoroff pathway, the pentose phosphate pathway and various hetero-and homo-fermentative pathways. The Entner-Doudoroff pathway differs from the linear glycolytic sequence in the type of C 6 intermediate that is formed and the aldolase that breaks it down: the Entner-Doudoroff pathway uses 6-phosphogluconate dehydratase (which converts gluconate-6-phosphate into 2-keto-3-deoxyphosphogluconate) and 2-keto-3-deoxyphosphogluconate aldolase (which forms pyruvate and glyceraldehyde-3-phosphate from the C 6 intermediate).
Although Escherichia coli has all of the enzymes that are needed to operate functional EMP and Entner-Doudoroff pathways 35 , many environmental bacteria use only the Entner-Doudoroff pathway, owing in part to the absence of 6-phosphofructokinase activity 81 . Pseudomonads exclusively use the EntnerDoudoroff pathway for sugar catabolism 35, 136 , which seems to enable a high tolerance to oxidative stress 79 . Nature Reviews | Microbiology Glucose Glucose-6-P Fructose-6-P Fructose-1,6-P 2
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Gluconate-6-P 2-Keto-3-deoxygluconate-6-P It was later discovered that strain mt2 harbours the TOL plasmid pWW0, which encodes a pathway for toluene and mxylene and/or pxylene biodegradation 75 . Strain KT2440 was one of the first bacteria to be certified as a biosafety strain for recombinant DNA experiments and applications, and it is officially classified as GRAS 76 (generally regarded as safe). Inspection of its ~6.2 Mb genome 77 has not only revealed the basis of many of its known characteristics but has also exposed some unan ticipated properties. One remarkable trait is the pres ence of >80 genes that encode oxidoreductases 78 , which enable growth on a broad range of aromatic substrates. At least five complete biodegradation pathways that are encoded in the chromosome have been characterized, which can proceed through βketoadipate, phenylacetyl coenzyme A, homogentisate, gentisate and homoproto catechuate as metabolic intermediates 50 . In addition, P. putida isolates that are similar to strain KT2440 have been found to carry plasmids that mediate the break down of naphthalene, 4chloronitrobenzene, 2,4xylenol and phenol 49 .
A closer look at the metabolic properties of this bacterium helps to show why it can host such a variety of biodegradation pathways (FIG. 5) . P. putida KT2440 oxidizes organic compounds via peripheral routes that eventually convert these substrates into glycolytic and tricarboxylic acid cycle intermediates -as do most heterotrophic bacteria. However, glycolysis in P. putida has a number of unique features. Several of the oxida tive steps are coupled to the reduction of NADP + to NADPH, which is used to generate anabolic precursors that are needed for bacterial growth and exploited as antioxidant currency under exogenous and endogenous stressful conditions 37, 79, 80 . The first metabolic model of the strain KT2440 was published in 2008 (REF. 81) , and this was quickly followed by two other variants 82, 83 . These models have been refined over time, and have been instrumental in taking steps towards the domestication of this microorganism -although expert knowledge is also needed to interpret and implement in silico pre dictions 79 . So far, the most complete metabolic network that has been proposed for KT2440 spans 1,071 reac tions and 1,044 metabolites and is related to 900 genes. Modelbased predictions of in silico phenotypes were recently refined by the integration of experimental data on the stoichiometric demands for anabolism and cel lular maintenance 84 -improving the predictive power of computational design -and data from deep RNA sequencing experiments 85, 86 . In addition, a compre hensive interaction database of P. putida KT2440 has been generated from three protein-protein interaction methods 87 (PutidaNET; see Further information), fur ther improving our understanding of the fundamental biology of this strain.
Getting genes in and out
The journey from finding a naturally occurring bac terium with interesting properties to producing a reli able and predictable chassis that can also deliver on the biotechnological promise of synthetic biology involves many steps. The challenges involved include the removal of nondesirable traits, the enhancement of advantageous traits, the insertion of new activities and the establish ment of a language for communicating instructions (receiving, if possible, some feedback in real time). Over coming these challenges involves genetic manipulations that range in complexity from simple singlegene dele tions and/or insertions to the implementation of complex genetic and metabolic circuits.
Deleting genes. The extant, single chromosome of P. putida KT2440 encodes 5,420 ORFs, 76.9% of which have an accredited function, 19.1% of which determine hypo thetical proteins and 4% of which encode products that are not represented in the databases 77, 88 (Pseudomonas Genome Database). A genetic toolbox for cutting and pasting both small and large genomic segments as well as executing allelic replacements and stably inserting new DNA segments into the target chromo some is crucial. Although the literature reports many vectors for making sitedirected deletions and muta tions in Gramnegative microorganisms 89 , many are suboptimal for making multiple directed changes in the genome of P. putida KT2440. Part of the problem is that this bacterium has relatively poor frequencies of DNA homologous recombination 90 . Fortunately, the adaptation of the chromosomeediting tools that were developed by Pósfai and colleagues to reduce the genomic size of E. coli 91 has resulted in an almost fail proof method for making seamless deletions in strain KT2440 (REFS 92, 93) . Using this method, a nonmotile variant of P. putida KT2440 was constructed, in which a ~70 kb region (that is, 1.1% of the genome) spanning 
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the genes that are needed for flagellar export and assembly had been deleted 94 . This attempt towards the implementation of a reducedgenome P. putida KT2440 variant as a microbial cell factory resulted in several physiological traits being enhanced in the nonflagel lated mutant, such as increases in the adenylate energy charge and NADPH/NADP + ratio. Separate efforts have been made to reduce the size of the P. putida Figure 5 | The metabolic heart of Pseudomonas putida KT2440. Lacking 6-phosphofructokinase, most Pseudomonas species metabolize C 3 and C 6 sugars via the Entner-Doudoroff pathway (instead of the Embden-Meyerhof-Parnas pathway). In the first step of hexose catabolism, glucose is transported through a dedicated ATP-binding cassette (ABC) uptake system into the cytoplasm, where it is phosphorylated to glucose-6-phosphate (glucose-6-P) and gluconate-6-P. By contrast, in the oxidative pathway, glucose can diffuse into the periplasm and be converted to gluconate and then to 2-ketogluconate; these intermediates are transported into the cytoplasm to be phosphorylated to gluconate-6-P and 2-ketogluconate-6-P. These upstream intermediates converge at the gluconate-6-P node, entering either the EntnerDoudoroff pathway or the pentose phosphate pathway. In the case of P. putida, the pentose phosphate pathway seems to have the most relevant role in NADPH supply, particularly via the activity of glucose-6-P dehydrogenase, which is represented by three iso-enzymes. All available data thus indicate that the metabolic core of KT2440 is optimally equipped for hosting redox reactions. This not only explains the abundance of P. putida strains among the best aerobic biodegraders of tough substrates but also advocates their use as a vessel of established (or evolving) new pathways that include intermediate faulty enzyme-substrate couplings. Eda, 2-dehydro-3-deoxyphosphogluconate aldolase; Edd, 6-phosphogluconate dehydratase; Eno, enolase; Fbp, fructose-1,6-bisphosphatase; Fda, fructose-1,6-bisphosphate aldolase; Gap, glyceraldehyde 3-phosphate dehydrogenase; Gcd, glucose dehydrogenase; Glk, glucokinase; GnuK, glucokinase; KguD, 2-ketogluconate 6-phosphate reductase; KguK, 2-ketogluconate kinase; Pgi, glucose-6-phosphate isomerase; Pgk, phosphoglycerate kinase; Pgl, 6-phosphogluconolactonase; Pgm, phosphoglyceromutase; PykA, pyruvate kinase; PykF, pyruvate kinase; Rpe, ribulose-5-phosphate 3-epimerase; RpiA, ribose-5-phosphate isomerase A; Tal, transaldolase; TktA, transketolase; TpiA, triosephosphate isomerase; Zwf, glucose-6-phosphate dehydrogenase. Putative iso-enzymes are indicated with their corresponding PP number (Pseudomonas Genome Database).
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KT2440 genome by random (rather than targeted) deletions of large chromosomal regions. Although ~7% of the genome has been erased using such a procedure 95 , this approach might be limited by the scattering of essential genes throughout the whole chromosome.
Inserting genes. What is the best procedure to insert new genes into a bacterium? Plasmid vectors have been -and still are -the workhorses for geneti cally engineering microorganisms at the laboratory scale, although they are not exempt from problems when used in industrial and environmental settings. Although broadhostrange vectors that are applicable to P. putida have been available since the beginning of the recombinantDNA era 96 , the architecture of such tools has only recently been subject to standardization efforts
. One example of the power of using for matted plasmid vectors in P. putida is the engineering of a strain to biodegrade the environmental pollutant 1,3dichloroprop1ene under conditions of limited oxygen supply 97 . This example showed the adequacy of using synthetic biology tools to domesticate P. putida KT2440, as this bacterium is not naturally endowed with the ability to thrive in the absence of oxygen or with the functions that are needed to mineralize 1,3dichloroprop1ene. In other cases, the objective is not only the acquisition of heterologous DNA fragments but also their stable integration in the chromosome. One possibility is to use the same recombinationbased genomeediting tools as the ones mentioned above, but such procedures can be timeconsuming. An alterna tive strategy is the use of Tn5based and Tn10based minitransposon vectors [98] [99] [100] , which can deliver multi ple DNA segments of unlimited size to the genome of P. putida as part of a hybrid mobile element. The dis advantages of this technique are related to the a priori uncertainty of the insertion site, which might affect expression levels owing to the uneven distribution of transcriptionally active segments within the bacterial genome 101 . But this same problem becomes an asset if the user wishes to explore various levels of expres sion of the same gene (or genes) by random insertion of the engineered transposon into the target genome 102 . Should this not be the case, other genetic systems can be used to direct insertions into specific chromosomal sites. Many transposon vectors are available, which exploit the preference of Tn7 to target cognate, single attTn7 sequences that are naturally present 103, 104 or that can be engineered 105 into the bacterial genome of choice. A more sophisticated alternative -particularly for very large DNA fragments -involves the exploitation of the integrase activity of an integrative or conjugative ele ment 106 , which delivers the DNA of interest into one or more specific sites of the target chromosome. As a whole, the tools that are listed above enable any genomic manipulation to be made in P. putida KT2440, paving the way towards rational domestication. The next step would be to enable the user to deliver instructions to a biological receiver and get some feedback in return, during or after implanting the desired functionality.
Engineering communication
Bacteria can sense physicochemical signals and trans late them into specific responses that most often involve turning on and off gene expression. Promoters con trolled by transcription factors that are responsive to exogenously added inducers 107 (for example, isopropyl βdthiogalactoside, arabinose or tetracycline) have been used to drive the expression of heterologous genes. Such manipulations, which subvert the natural functions of transcription factor-promoter pairs, are a primitive but us eful way of programming cells to follow specific instructions. The number of such regulatory pairs that are applicable to P. putida is enormous, and many are located within mobile elements (that is, plasmids and transposons) that bear xenobiotic biodegradation path ways 50 . The promiscuous nature of such itinerant operons forces the encoded enzymes and regulatory elements to evolve to work well in different hosts (that is, they are to some extent orthogonal). On this basis, environmental
Box 1 | The Standard European Vector Architecture
Compositional and functional standardization of biological parts is one of the trademarks of contemporary synthetic biology 12, 128, 129 . The Standard European Vector Architecture 130 (SEVA; see further information) initiative was recently launched as a coherent resource of molecular tools that are subjected to a concise, minimalist and standardized format and nomenclature and that are fully compatible with old and new cloning protocols and DNA-assembly methods. Vectors that follow the SEVA format are composed of three variable modules: a cargo, a replication origin (oriV) and an antibiotic resistance marker (see the figure) 130 . Target sites for rare restriction enzymes, which are used to (inter)change the functional modules, are explicitly shown (Ascl, Fsel, Pacl, PshAl, Spel and Swal). Segments are separated by three permanent regions, which are shared by all vectors, the T 0 and T 1 transcriptional terminators and the oriT conjugation origin for transferring the plasmids into various bacterial recipients. Such simple rules allow for the generation of a large collection of vectors that cover almost all genetic and metabolic engineering necessities of Pseudomonas putida KT2440 and other Gram-negative bacteria: genome editing (that is, deletions, insertions and allelic replacements), heterologous gene expression, implementation of logic circuits, biosensors with optical readouts and many others. The reader is referred to SEVA for a complete description of the available vectors and their specific properties. The SEVA format may become a fundamental reference to speed up biosystems engineering beyond laboratory applications. Nature Reviews | Microbiology genomes and metagenomes are a rich source of transcrip tion factor-promoter pairs that respond to the most diverse repertoire of chemical effectors. Just to name a few, the repertoire of inducible expression systems that are operational in P. putida KT2440 include those that respond to xylenes (XylR 108, 109 ), mtoluate (XylS Creating a functional communication system involves combining various regulatory events and types of com mands that, at some point, result in a deterministic deci sion. Bacterial promoters can be faithfully described using Boolean formalisms under which each regula tory event results from the action of binary gates that compute up to two inputs into a single output. Such logic networks help to explain the architecture and connectivity of naturally occurring regulatory circuits in P. putida (for example, the abovementioned TOL system 111 ). The similarity of transcriptional networks to electronic circuits also stimulated the design of logic gates that are artificially assembled from bacterial regulatory parts. These devices process specific signals and can be combined with others to implement simple computa tions (for example, toggle switches, pulse generators, oscillators and memory devices). Although they have mostly been implemented in E. coli thus far, they are also applicable to P. putida, and this is currently an active area of research. Such manipulations are not restricted to transcription factor-promoter pairs, but also enable new inputs to transcription factors themselves, as well as to housekeeping proteins (for example, GroEL 112 ) by engineering proteasecleaving sites in their structure and thereby modifying their logic behaviour 113 . Communication is a twoway process: how can researchers get some feedback on the fate of their orders to bacterial cell factories? Visual inspection of cells often provides little information on their physiological or catalytic performance. One approach is the use of proteinbased, transcription factorbased and RNAbased intracellular sensors of specific physiological descriptors coupled to optical reporters. In combination, the simul taneous quantitative monitoring of several parameters would enable the user to assess the performance of an engineered process. A few in vivo fluxsensing 114 and metabolitesensing 115, 116 devices are available for E. coli. Functional variants of these systems adapted to pseudomonads would be a welcome addition to the collection of biosensors that are already available for these bacteria 51, 115, 117 .
Programming population behaviour. A further step in designing rational P. putida-user interactions is engi neering chemical signalling. Quorumsensing agents have been used for this purpose 118 , but the choice of useful molecules is limited. Once more, the biodeg radation pathways that are present in P. putida are sources of parts and devices that can be refactored for programming cell-cell communication. One exam ple is a sender P. putida strain that harbours the TOL pathway, which processes environmental toluene as the input cue and generates benzoate as the output signal 119 .
Box 2 | String-weight engineering for determining complex parameters
Before the scientific era, builders of intricate structures often needed to estimate parameters that were not amenable to prediction using the analysis and calculation tools that were available at the time.
Architects, such as Antoni Gaudí (1852-1926), found ways to solve the problem by making string models of the building of interest, in which weights were hung at crucial places to reveal the effect of local structures on the geometry of the whole object. By turning the model upside down, the optimal arches and angles for maintaining a robust structure could be inferred (see part a of the figure) . This is an example of how optimal complex designs can be achieved by merging forward-engineering with nature-inspired problem solving.
Uncertainties about the best combination of enzymatic steps (see part b of the figure; steps 1-4) to convert a substrate into a product include, among other things, the ability to reach a suitable level of transcription (that is, the function of the promoter and the transcriptional factor (TF)) and the need to identify adequate intergenic regions (IGR) that ensure the necessary stoichiometry in protein production, as well as mRNA stability and termination issues. Current efforts to solve the multiscale design of robust bacterial catalysts using combinatorial and evolutionary approaches 127, [131] [132] [133] qualify within the string-weight engineering concept.
Diffusion of benzoate is sensed by a second, receiver P. putida strain that processes benzoate as the input to produce a visual output. Given the many possible enzyme-transcription factor-inducer combinations, the opportunities for designing complex population performance are huge. The physical distribution of bacteria in specific physico chemical niches can also be engineered. P. putida KT2440 forms biofilms on abiotic surfaces, the shape of which is determined by the physiological condition of cells, nutrient avail ability, the surface chemistry of the growth substrate and nutrient gradients. Catalytic biofilms have been explored with Pseudomonas strains by comparing their redox capabilities for noctanol and (S)styrene oxide production in planktonic growth (in a stirred tank) and on a solid substrate (in a membrane reac tor) 120 . Biofilmbased systems at an industrial scale could become a realistic alternative to traditional bioprocesses for the bioproduction of fine chemicals.
The challenges ahead
Despite the potential of P. putida discussed above, the reality is that, when a promising genomic chassis is combined with a welldefined genetic or metabolic implant, the outcome cannot be entirely anticipated. Although some genomeedited laboratory strains of E. coli are predictable to an extent 121 and current tech nologies enable the synthesis of DNA sequences the size of a small bacterial genome 122 , the lack of under standing of many basic biological facts (for example, the interplay between the genetic programme and the metabolic network 37 ) is still a considerable hurdle in synthetic biology.
In the meantime, how far can we progress in the rational design of biological systems? Although indi vidual circuits that have a small number of components can be engineered to an acceptable degree of predict ability, their connection and interplay within an exist ing molecular landscape often result in a level of com plexity that cannot currently be designed from first principles. Instead, finetuning the inputs to implanted devices with the corresponding outputs requires what we call 'biological string-weight engineering' . This term originates from the nonmathematical methods that are used to find optimal parameters for distributing weights in a complex structure by upending a string model of the structure, with weights attached at critical heights (this method was used by the Spanish architect Antoni Gaudí 123 )
. Nature itself (owing to gravity in this case) provides the solution to an intricate multiscale problem that could not be solved using available formal isms. This enables the blending of forwardengineering (that is, the rational assembly of components to the point that is possible using current technology) with gravita tion towards functional optimality. Within this concep tual framework, the connections among components of a preassembled biological device can be allowed to explore a variety of input-output transfer functions 117 . The objective is set and the circuitry is left to explore in vivo the combination of parameters that result in the desired property (for example, a relevant phenotype).
String-weight engineering may include directed evolu tion steps to enable exploration of the parameter space by the predesigned system.
Once a given optimum is reached, the ultimate chal lenge is to protect the structure from changes and even tual collapse. Evolvability -an inherent property of DNAbased biological systems -is possibly the main obstacle to engineering reliable living objects. Some in vivo approaches have been proposed to avoid the occurrence of mutations, mostly by increasing genomic stability. For example, it is possible to counterselect variations in specific DNA sequences by interfacing a conditional lethality circuit with DNA mismatchrepair systems 124 . Again, nature offers remarkable examples of bacteria with lifestyles that map between high and lowmutation rates (for example, P. aeruginosa 125 and Buchnera aphidicola 126 ), from which we can take inspira tion. Chassis that are programmed to switch between a highmutation and a lowtononemutation evolution ary programme would constitute excellent frames for designing reliable cell factories. Such an objective can be targeted by the transient expression of a hypermuta tor phenotype 127 and the conditional inactivation of the SOS system (thereby implementing the string-weight engineering concept that is described above).
Outlook
One key endeavour in contemporary synthetic biology is the search for an optimal and realistic genomic chas sis for industrial, largescale applications 18 . Although one can imagine synthetic life forms that will be pro grammed 'à la carte' in the future for a range of uses, such objects are unlikely to reach bioindustry anytime soon. In the short term, synthetic biology agents will necessarily merge desirable preexisting traits (the basis of which might not be fully understood at the time) with rationally engineered implants. It therefore makes sense to use as the starting point bacteria that nature has already selected to thrive under many of the deman ding conditions that are involved in industrial operations. Reaching the point at which bacteria can be designed with complete reliability still requires the clarification of much of their fundamental biology, in particular the interplay between metabolism and genetic stabil ity, as well as a better understanding of live systems as informationprocessing chemical machines. Whereas E. coli 121 and Mycoplasma spp. 122 are the most useful models for addressing such fundamental questions, the industrial performance of these bacteria is limited by their inherent genetic programme, which reflects their original ecological niches. Other species notwithstand ing, we argue that P. putida holds superior value for the generation of designer wholecell catalysts -includ ing in both upstream processes (that is, biochemical reactions) and downstream processes (that is, product recovery). It is likely that -at least in the medium term -synthetic biology agents will show more resemblance to bacterial cyborgs, that is, with natural properties that are merged with implanted traits, than to robots, that is, systems that are entirely engineered from first principles.
